Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 CAD | -1.19% | -1.78% | -50.45% |
Sales 2024 * | - | Sales 2025 * | 1.04M 762K | Capitalization | 26.41M 19.31M |
---|---|---|---|---|---|
Net income 2024 * | -74M -54.1M | Net income 2025 * | -54M -39.48M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 25.3 x |
P/E ratio 2024 * |
-0.24
x | P/E ratio 2025 * |
-0.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.93% |
Latest transcript on Aptose Biosciences Inc.
1 day | -1.19% | ||
1 week | -1.78% | ||
Current month | -1.78% | ||
1 month | -7.78% | ||
3 months | -38.75% | ||
6 months | -55.97% | ||
Current year | -50.45% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.66 | -1.19% | 3 900 |
24-05-10 | 1.68 | -0.59% | 200 |
24-05-09 | 1.69 | -1.17% | 4,010 |
24-05-08 | 1.71 | +0.59% | 1,910 |
24-05-07 | 1.7 | +0.59% | 4,988 |
Delayed Quote Toronto S.E., May 13, 2024 at 10:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.45% | 19.33M | |
+23.34% | 44.96B | |
+0.56% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.93% | 26.08B | |
-21.39% | 19.03B | |
+6.23% | 12.75B | |
+28.78% | 12.06B | |
-3.56% | 11.75B |
- Stock Market
- Equities
- APS Stock